Journal
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
Volume 32, Issue 3, Pages 369-389Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2019.01.002
Keywords
Ankylosing spondylitis; Axial spondyloarthritis; Psoriatic arthritis; Cardiovascular disease; Atherosclerosis; Arrhythmias; Aortic root
Categories
Funding
- University of Washington
- ASAS international society
- Spondylitis Association of America
- Russel Engelman Rheumatology Research Center at the University of California, San Francisco
Ask authors/readers for more resources
The cardiovascular burden in inflammatory rheumatic diseases is well recognized. Recently, this burden has been highlighted in ankylosing spondylitis (also known as radiographic axial spondy-loarthritis) and psoriatic arthritis. We review the cardiovascular morbidity and mortality in these diseases, as well as the prevalence and incidence of traditional cardiovascular risk factors. We examine the contribution of anti-inflammatory therapy with nonsteroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, and TNF inhibitors on the cardiovascular risk profile. Finally, we examine the available recommendations for the management of cardiovascular comorbidity, as they apply to the spondyloarthritis population. (C) 2019 Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available